Full-Length L1CAM Promotes Metastasis
Author Information
Author(s): Stephanie Hauser, Laura Bickel, Dirk Weinspach, Michael Gerg, Michael K. Schäfer, Marco Pfeifer, John Hazin, Florian Schelter, Ulrich H. Weidle, Juliane Ramser, Juliane Volkmann, Alfons Meindl, Manfred Schmitt, Florian Schrötzlmair, Peter Altevogt, Achim Krüger
Primary Institution: Institut für Experimentelle Onkologie und Therapieforschung Klinkum rechts der Isar der Technischen Universität München
Hypothesis
Is the full-length L1CAM variant responsible for promoting metastasis in ovarian carcinoma compared to its splice variant?
Conclusion
The study identifies full-length L1CAM as the key isoform promoting metastasis, contrary to the previously held belief that the splice variant is the main contributor.
Supporting Evidence
- Both FL-L1CAM and SV-L1CAM were expressed in benign and malignant ovarian tumors.
- Only FL-L1CAM promoted experimental lung and liver metastasis in mice.
- Elevated expression of FL-L1CAM correlated with increased invasive potential and elevated MMP-2 and MMP-9 expression.
Takeaway
This study shows that a specific version of a protein called L1CAM helps cancer spread, while another version thought to be important does not.
Methodology
The researchers analyzed mRNA levels of L1CAM variants in ovarian tumor samples and conducted experiments on cancer cell lines to assess the impact of L1CAM on metastasis.
Potential Biases
Potential bias in interpreting the roles of L1CAM variants due to the focus on specific experimental conditions.
Limitations
The study primarily focuses on specific cancer types and may not generalize to all cancers.
Participant Demographics
Patients with ovarian tumors and peritoneal metastases.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website